Eni will guarantee Dompé researchers access to its laboratories, support from the company's specialized staff, and use of its HPC5 supercomputer
The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
The company's Bavla site was successfully jointly inspected by the EDQM and Italian Medicines Agency (AIFA)
Opinion granted based on positive disease-free survival results from the Phase 3 KEYNOTE-091 trial
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older
Subscribe To Our Newsletter & Stay Updated
